An IgG subclass test separates total immunoglobulin G into IgG1, IgG2, IgG3, and IgG4. These four antibody groups differ in abundance, the antigens they recognize, and how strongly they activate other immune defenses. Testing is most useful when a person has recurrent bacterial respiratory infections despite a normal or near-normal total IgG level. A low subclass value alone does not prove immune deficiency: healthy people can have an isolated low result, children mature at different rates, and levels vary between samples. A clinically meaningful diagnosis usually requires repeated low age-adjusted levels, a compatible infection pattern, and evidence that specific antibody responses—often to pneumococcal vaccine antigens—are inadequate. High subclass results have different implications; IgG4 elevation, for example, is not diagnostic of IgG4-related disease. The full interpretation includes total immunoglobulins, vaccine titers, medicines, lung health, age, treatment history, and a careful search for other causes of repeated infection.
- IgG1 usually makes up about 60–70% of total IgG, IgG2 about 20–30%, IgG3 about 5–8%, and IgG4 roughly 1–4%.
- IgG2 deficiency is often considered when recurrent ear, sinus, or lung infections involve encapsulated bacteria and polysaccharide antibody responses are weak.
- A subclass deficiency should be confirmed with age-specific repeat testing; one low result without symptoms is often not clinically significant.
- Normal subclass levels do not guarantee normal vaccine responses, and low subclass levels do not automatically require immune-globulin treatment.
- Children, especially those under 10, need cautious interpretation because IgG2 and IgG4 mature later than IgG1 and IgG3.
- High IgG4 can occur in allergy, infection, autoimmune disease, cancer, and healthy people as well as IgG4-related disease.
Table of Contents
- What Each IgG Subclass Does
- Why and How the Test Is Ordered
- Reference Ranges and Age-Related Pitfalls
- Low IgG1, IgG2, IgG3, or IgG4
- Diagnosing Clinically Significant Subclass Deficiency
- High Subclass Levels and IgG4-Related Disease
- Treatment, Monitoring, and Long-Term Outlook
- When Specialist or Urgent Care Is Needed
What Each IgG Subclass Does
All four subclasses share the basic Y-shaped IgG structure, but small differences in their constant regions change how they bind immune receptors, activate complement, and move through tissues. The subclasses are not four versions of the same test result; each contributes differently to defense.
IgG1 is the largest fraction of serum IgG. It responds strongly to protein antigens, including many viral proteins, bacterial toxins, and protein-containing vaccines. Because IgG1 is so abundant, a substantial IgG1 deficiency often lowers total IgG as well. An apparently isolated IgG1 reduction should therefore be checked against the total IgG value and the laboratory method.
IgG2 is especially important for antibodies against polysaccharide capsules. These sugar-rich coatings help organisms such as Streptococcus pneumoniae and Haemophilus influenzae evade immune clearance. Low IgG2 may be associated with repeated otitis, sinusitis, bronchitis, or pneumonia, particularly when pneumococcal serotype responses are poor. IgG2 develops more slowly in childhood than IgG1.
IgG3 responds efficiently to many protein antigens and is particularly effective at activating complement. It has a shorter half-life than the other subclasses, so concentrations can vary more. Some patients with low IgG3 report recurrent viral or bacterial respiratory infections, but the clinical relevance depends on reproducibility and antibody function.
IgG4 is normally the least abundant subclass. It rises after repeated or long-term antigen exposure and is associated with immune tolerance in some settings, including allergen immunotherapy. IgG4 activates complement poorly and can exchange half-molecules with other IgG4 antibodies, creating functionally unusual antibodies. Very low IgG4 can be found in healthy people, especially children, so isolated deficiency is difficult to diagnose.
| Subclass | Approximate share of total IgG | Common immune role | Important caution |
|---|---|---|---|
| IgG1 | 60–70% | Protein antigens, toxins, many viral responses | Low IgG1 often lowers total IgG |
| IgG2 | 20–30% | Polysaccharide capsules of bacteria | Matures slowly in children |
| IgG3 | 5–8% | Protein antigens and strong complement activation | Short half-life and greater variability |
| IgG4 | 1–4% | Repeated antigen exposure and immune modulation | Low values are common; high values are nonspecific |
A routine total IgG test combines all four. Subclass testing adds detail, but it does not directly measure whether antibodies bind and neutralize a particular pathogen. Functional antibody studies remain essential when infection risk is the concern.
Why and How the Test Is Ordered
Doctors generally do not use IgG subclass testing as a first-line screen for every frequent cold. It is considered after the clinical history suggests an antibody problem and basic tests—total IgG, IgA, and IgM—are normal or only mildly abnormal.
Situations that may justify testing include:
- Recurrent bacterial sinusitis, ear infections, bronchitis, or pneumonia
- Infections caused by encapsulated bacteria
- Bronchiectasis without a clear cause
- Poor response to pneumococcal vaccination
- Selective IgA deficiency with significant respiratory infections
- Persistent infection problems despite normal total immunoglobulins
- Follow-up of a previously confirmed subclass abnormality
An immunoglobulin panel should usually accompany the subclass test. If total IgG is clearly low, the broader hypogammaglobulinemia may be more important than the subclass distribution. If IgA or IgM is also low, clinicians consider disorders such as common variable immunodeficiency rather than labeling the finding as a purely isolated subclass deficiency.
The sample is ordinary serum from a venous blood draw. Fasting is not usually required. Acute infection can change antibody levels, so a result obtained during significant illness may be repeated after recovery. Immune-globulin replacement makes subclass measurement difficult to interpret because the infused product supplies all four subclasses from donors.
Subclass testing is not a reliable way to diagnose food allergy, environmental allergy, autoimmune disease, or general “immune weakness.” It also should not be used as a broad wellness screen. Low values are common enough that indiscriminate testing can create false concern and lead to unnecessary treatment.
A good test order starts with a precise clinical question: Is there evidence of a selective antibody-production problem that could explain recurrent infections despite an acceptable total IgG concentration? The answer requires both laboratory and clinical evidence.
Reference Ranges and Age-Related Pitfalls
Subclass reference intervals vary substantially by laboratory. One adult laboratory may report IgG1 around 3.8–9.3 g/L, IgG2 2.4–7.0 g/L, IgG3 0.2–1.8 g/L, and IgG4 0.04–0.86 g/L, while another uses wider limits. The assay platform, calibration, population, and statistical method all influence the interval. Results must be compared with the range printed on that specific report.
Children need age-matched interpretation. IgG1 and IgG3 approach adult concentrations earlier, often by early school age. IgG2 and IgG4 rise more slowly and may not resemble adult levels until around age 10 or later. A low IgG2 in a young child may reflect normal immune maturation rather than permanent deficiency.
Three analytical issues commonly cause confusion:
- Subclass totals may not equal the separately measured total IgG exactly. Different reagents and calibration can create modest discrepancies.
- A value below the 2.5th percentile is not automatically disease. By definition, some healthy people fall below a statistical lower limit.
- IgG4 may be below detection in healthy individuals. Isolated “IgG4 deficiency” is especially difficult to interpret without recurrent infections and impaired functional responses.
Repeat testing is important because subclass levels fluctuate. A clinically significant deficiency is generally documented on at least two measurements separated in time, ideally when the patient is not acutely ill and before immune-globulin treatment. The same laboratory is useful for comparison when possible.
The whole pattern matters. If IgG1 is low and total IgG is low, this is not a classic isolated subclass deficiency. If IgG2 is low but pneumococcal responses are protective and infections are mild, the laboratory finding may have little clinical consequence. If IgG2 is repeatedly low, vaccine responses are poor, and bacterial pneumonias recur, the result is much more meaningful.
Age, prematurity, recent vaccination, immunosuppressive treatment, protein loss, and blood cancers can all affect subclass levels. A child’s result should be interpreted alongside growth, infection type, vaccine history, and whether other parts of the immune system are normal.
Percentages can be misleading as well. A subclass may account for a larger percentage of total IgG only because another subclass is low, while its absolute concentration remains normal. Clinicians therefore use the measured concentration in mg/dL or g/L, not the percentage alone. Unit conversion also matters: 1 g/L equals 100 mg/dL.
Low IgG1, IgG2, IgG3, or IgG4
The symptoms of a clinically important subclass deficiency usually reflect repeated airway infection rather than a unique symptom for each subclass. Common organisms include pneumococcus and H. influenzae. Recurrent inflammation can damage the sinuses and bronchi, making future infections easier to acquire.
Low IgG1 often overlaps with low total IgG because IgG1 contributes most of the total. Clinicians look for broader antibody deficiency, medication effects, protein loss, or evolving common variable immunodeficiency. Calling it isolated IgG1 deficiency without considering total IgG can obscure the larger problem.
Low IgG2 is the best-known subclass association with poor polysaccharide antibody responses. Affected patients may have recurrent otitis, sinusitis, and pneumonia. Yet some people with low IgG2 make adequate pneumococcal antibodies and remain healthy. Others have normal IgG2 but still fail to respond to polysaccharide antigens, a condition often called specific antibody deficiency.
Low IgG3 has been reported in adults with recurrent respiratory infections and sometimes viral susceptibility. Because IgG3 turns over relatively quickly and laboratory methods differ, confirmation is essential. The result becomes more persuasive when infections are documented and vaccine responses are also weak.
Low IgG4 rarely stands alone as a clear explanation. IgG4 concentrations are small, age dependent, and sometimes undetectable in healthy people. Combined IgG2 and IgG4 reductions may be more relevant than isolated low IgG4, particularly when pneumococcal responses are poor.
Subclass reductions can be secondary to rituximab and other B-cell therapies, chemotherapy, corticosteroids, anticonvulsants, blood cancers, kidney protein loss, or protein-losing intestinal disease. The cause should be identified before assuming a primary inherited deficiency.
Allergy and asthma can coexist with subclass deficiency, but recurrent wheeze does not necessarily mean infection. Clinicians distinguish viral-triggered asthma, chronic sinus inflammation, aspiration, cystic fibrosis, primary ciliary dyskinesia, and anatomic airway problems from antibody failure.
Diagnosing Clinically Significant Subclass Deficiency
A useful diagnosis requires three elements: a convincing clinical phenotype, persistently low age-adjusted subclass levels, and evidence that antibody function is impaired. Without all three, the label may not explain the patient’s symptoms.
The infection record should document more than “gets sick often.” Helpful details include the number of antibiotic courses, culture results, radiographically confirmed pneumonias, hospitalizations, infection-free intervals, and whether lung or sinus damage has developed. The pattern is stronger when infections are bacterial, recurrent, and involve the ears, sinuses, or lower respiratory tract.
Functional testing often centers on pneumococcal serotype antibodies. A clinician may measure baseline titers, administer an age-appropriate pneumococcal vaccine when indicated, and repeat titers several weeks later. The pneumococcal antibody titer test evaluates responses to multiple serotypes rather than a single total value.
Interpretation is not simply “above or below one number.” Age, previous conjugate vaccines, baseline concentrations, final concentrations, fold rise, and the proportion of serotypes responding all matter. Protein-antigen responses may be checked with tetanus antibody testing or diphtheria titers.
Additional studies may include:
- Total IgG, IgA, and IgM repeated over time
- Complete blood count and lymphocyte subsets
- Complement testing if the infection pattern suggests it
- Chest imaging and pulmonary-function testing for recurrent pneumonia
- Sweat chloride, ciliary testing, or swallowing evaluation when nonimmune causes are plausible
- Review of medications and protein loss
- Genetic testing in selected severe, familial, or syndromic cases
A diagnosis can change over time. Some children normalize subclass levels as the immune system matures. A smaller group later develops broader hypogammaglobulinemia or common variable immunodeficiency. Periodic reassessment prevents both premature lifelong labeling and missed progression.
Four example patterns show why the same laboratory flag can lead to different conclusions. A healthy 7-year-old with a slightly low IgG2, normal vaccine responses, and ordinary viral colds may need observation rather than an immune-deficiency diagnosis. An adult with repeatedly low IgG2, several culture-documented pneumococcal infections, and poor post-vaccine serotype titers has a much stronger case for clinically significant antibody deficiency. A patient with low IgG1, low total IgG, and low IgA needs evaluation for broader hypogammaglobulinemia rather than isolated subclass deficiency. A person with normal subclasses but poor pneumococcal responses may have specific antibody deficiency, showing that functional testing can be more important than subclass concentration.
False reassurance is also possible. A laboratory may report all four subclasses within range even though a patient has lost antibodies against particular pneumococcal serotypes, has impaired memory B cells, or is developing a wider immune disorder. Conversely, a low value found during one acute illness may normalize and never correlate with infections. Repeating both the clinical assessment and the laboratory studies prevents the test from being treated as a fixed identity.
Vaccination history should be reconstructed carefully. Conjugate pneumococcal vaccines attach capsule sugars to a protein carrier and stimulate a T-cell-dependent response. The older polysaccharide vaccine exposes capsule sugars without that carrier. Prior doses affect baseline titers and the meaning of a later challenge. The laboratory also may not measure every serotype contained in a vaccine. An immunologist chooses the vaccine and timing based on age, previous doses, local recommendations, and the diagnostic question.
Antibiotic use can blur the phenotype. Frequent early treatment may prevent pneumonia from being confirmed, while repeated viral illnesses may lead to unnecessary antibiotics and an exaggerated impression of bacterial susceptibility. Culture reports, chest radiographs, and response to treatment help separate these situations. Dental infections, skin abscesses, fungal disease, and opportunistic infections are less typical of an isolated subclass problem and may direct testing toward neutrophils, T cells, diabetes, or anatomic causes.
High Subclass Levels and IgG4-Related Disease
High subclass values are interpreted differently from deficiency. IgG1 or IgG3 may rise during infection, autoimmune inflammation, or broad polyclonal immune activation. IgG2 can increase with chronic antigen exposure. These values rarely identify a disease by themselves.
Elevated IgG4 receives particular attention because it can occur in IgG4-related disease, a fibroinflammatory condition that may affect the pancreas, salivary glands, tear glands, bile ducts, kidneys, lungs, lymph nodes, retroperitoneum, and other organs. However, serum IgG4 is neither sufficiently specific nor sufficiently sensitive to establish the diagnosis.
A high IgG4 result may also appear with allergy, asthma, parasitic infection, autoimmune disease, chronic infection, cystic fibrosis, inflammatory bowel disease, pancreatic cancer, lymphoma, and other conditions. Some healthy people have elevated concentrations. Conversely, a person with biopsy-proven IgG4-related disease can have a normal serum level.
When organ findings raise concern, clinicians combine imaging, other laboratory results, clinical pattern, and often tissue biopsy. The pathology looks for characteristic lymphoplasmacytic inflammation, fibrosis, and increased IgG4-positive plasma cells in the correct context. An isolated high result should not lead directly to steroids or other immune suppression.
Subclass tests can also be affected by a monoclonal protein. A plasma-cell clone may produce one IgG subclass and distort the total. Serum protein electrophoresis, immunofixation, and free light chains are more appropriate when anemia, kidney dysfunction, bone pain, high calcium, neuropathy, or unexplained protein elevation suggests a monoclonal gammopathy.
Treatment, Monitoring, and Long-Term Outlook
Treatment targets the clinical problem, not the subclass number. An asymptomatic person with one low value usually does not need treatment. Patients with documented infections may benefit from prompt culture-guided antibiotics, vaccination, nasal or airway care, smoking avoidance, and management of asthma or structural lung disease.
Some patients with recurrent bacterial infections use prophylactic antibiotics during high-risk seasons or continuously under specialist supervision. The choice depends on organisms, allergy history, local resistance, and infection frequency. Airway-clearance therapy is important when bronchiectasis is present.
Immune-globulin replacement may be considered when all of the following are convincing: recurrent or serious infections, persistently low subclass levels or another antibody abnormality, impaired vaccine responses, and inadequate control with standard preventive measures. Replacement supplies pooled IgG with all subclasses, so it is not a targeted “IgG2 infusion.”
The decision should include a planned trial period and measurable outcomes, such as fewer pneumonias, fewer antibiotic courses, or improved school and work attendance. Infusion side effects, cost, access, thrombosis risk, kidney risk, and the burden of ongoing therapy must be balanced against expected benefit.
Children may outgrow the laboratory abnormality. Reassessment after a stable period can include repeat immunoglobulins and functional antibodies once infused IgG has cleared, if a specialist believes a supervised treatment pause is safe. Adults with secondary deficiency may improve after B-cell recovery or control of protein loss, although recovery is variable.
Monitoring should also look beyond infection counts. Chronic cough, reduced exercise tolerance, or repeated pneumonias may justify lung imaging and pulmonary follow-up. Autoimmune disease can coexist with antibody deficiency and should be evaluated on its own merits.
Families can improve follow-up by keeping a concise infection log with dates, diagnosed site, fever, cultures, antibiotic name, treatment duration, missed school or work, and whether imaging confirmed pneumonia. This record gives the specialist a more reliable outcome measure than memory alone. It also shows whether preventive measures are reducing bacterial disease or merely changing the number of clinic visits.
When Specialist or Urgent Care Is Needed
Referral to an allergist-immunologist is appropriate for recurrent pneumonia, bronchiectasis, poor vaccine responses, repeatedly low subclasses, low total IgG or IgA, unusual infections, or a family history of immune deficiency. A specialist can distinguish a meaningful defect from an incidental laboratory finding and coordinate vaccine-response testing.
Seek urgent care for breathing difficulty, blue lips, confusion, severe dehydration, rapidly worsening fever, a stiff neck, low blood pressure, or other signs of sepsis or meningitis. A subclass result should never delay treatment of an active serious infection.
For most patients, careful confirmation prevents overdiagnosis. The combination of infection pattern, repeat age-adjusted subclass measurements, and functional antibody responses determines whether the test reflects true immune deficiency.
References
- Reappraisal of IgG subclass deficiencies: a retrospective comparative cohort study 2025
- Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases 2023 (Review)
- IgG Subclass Deficiency 2023 (Review)
- IgG subclass deficiencies 2025
- Clinical features and treatment outcomes in children with immunoglobulin G subclass deficiencies: a retrospective study 2025
- IgG Subclasses (IgG 1/2/3/4) 2026
Disclaimer
This article is for education and cannot diagnose an IgG subclass deficiency or determine whether immune-globulin treatment is appropriate. Subclass ranges and vaccine-response criteria vary by age, assay, immunization history, and clinical setting. Serious infection symptoms require prompt medical care regardless of laboratory results.
